CG Invites Co., Ltd. (KOSDAQ: A083790)
Health Care · Biotechnology · KR
₩800.00
-4.19% today · -50.3% 1Y
CG Invites Co., Ltd. (KOSDAQ: A083790) operates in the Biotechnology industry within the Health Care sector. The company is valued at $44.39M.
Over the last twelve months the share price has lost 50.3%, trading between 711.00 and 1.99K.
Tweenvest scores CG Invites Co., Ltd. across four factors: quality 31/100, value 65/100, growth 100/100. Its strongest factor is growth.
A083790 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.39M
- Revenue (TTM)
- $19.20M
- P/E
- —
- EPS
- -43.07
- Dividend yield
- —
- Beta (5Y)
- 0.04
- 52-week high
- ₩1,985.00
- 52-week low
- ₩711.00
- Avg volume (3M)
- —
- Shares outstanding
- 76.89M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.72 | +0.35% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $445.50 | +0.74% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.06 | -0.48% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.